3.08 (-3.45%)

T-O: 3.25 (08:59:00)
Last updated: 17:00

Fundamental   5.8  
Technical   5.8  
Total Score   11.6  

 Insti+   Sector Trend+ 


iSaham Fundamental Trend

FCON: 0.63 | Sharpe Ratio: 0.79 | LTS: 8.18

Quarter Reports

Trailing Dividend

Financial Ratios

EPS 8.01 sen
Trailing PE (Sector Median: 28.5) 37.4
PEG -4.63
Altman Z 1.3
Beaver 0.029
Current Ratio 1.71
Debt-Equity (DE) Ratio 0.77
FCF Yield -0.0 %
Dividend Per Share (DPS) 6.0 sen
Revenue QoQ 5.54 %
Revenue YoY 13.36 %
Profit QoQ -6.25 %
Profit YoY 5.65 %
NTA QoQ 5.33 %
Profit Margin (Sector Median: 3.7) 9.3 %
ROE 10.05 %
ROIC 7.93 %
Dividend Yield (DY) 1.95 %

Fair Value

iSaham Fair Value: 0.69

Discounted Cash Flow (DCF)5.0% Growth 0.69
Discounted Cash Flow (DCF)-2.8% Growth 0.38
Relative Valuation 2.35
Graham Formula 0.6
Graham Number 1.21
Net Tangible Asset (NTA) 0.79

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 424.73
Expected Revenue (M) 4566.99
Expected Growth (%) 33.0



Market Cap: 2035 M.

Number of Shares: 661 M.

Float: 40.43%.

Stock highly correlated with



PENTA (82%)

VITROX (82%)

CCM Duopharma Biotech Berhad, an investment holding company, is engaged in the manufacture, distribution, import, and export of pharmaceutical products and medicines in Malaysia. It offers various over the-counter products, including oral antibiotics, cough syrups, analgesic/anti-pyretics, anti-bacterial mouthwash, children's vitamins, haemodialysis solutions, dental cartridges, and eye drop preparations. The company exports its products to various countries, including Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. Founded in 1979, the company is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.

Sectors: Consumer Products, Healthcare, Pharmaceuticals, Technology

Code: 7148

Website: http://duopharmabiotech.com/

Related Links: Bursa | Annual Report | Announcement

AGM Doorgift: Pharmacy Products + RM10 TnG (2019) | AGM Announcement

Top Shareholdings

Updated on 25-Mar-2020

Shareholder Value (M)
Permodalan Nasional Berhad 977.97
Employees Provident Fund Board 176.02
Amanah Saham Bumiputera 92.4
Billion Victory Sdn Bhd 52.61
Public Islamic Treasures Growth Fund 22.2
Norges Bank 20.93
Manulife Investment Shariah Progressfund 20.78
Kumpulan Wang Persaraan (Diperbadankan) 15.73
Principal Dali Opportunities Fund 14.23
Eastspring Investmentssmall-Cap Fund 12.92
Manulife Investment Progress Fund 12.91
Lembaga Tabung Haji 12.39
Affin Hwang Aiiman Asia (Ex Japan) Growth Fund 10.36
Amanah Saham Malaysia 3 9.59
Tokio Marine Life Insurance Malaysia Bhd 8.72
Principal Islamic Small Cap Opportunities Fund 8.41
Affin Hwang Growth Fund 7.5
Ooi Keng Tan 6.79
CIMB-Principal Small Cap Fund 6.6
Petroliam Nasional Berhad 6.49
Gibraltar BSN Aggressive Fund 6.12
Affin Hwang Principled Growth Fund 6.09
Medical Fund 5.71
Credit Suisse 5.7
Amtotal Return 5.43
Hong Leong Assurance Berhad 5.31
Areca Equitytrust Fund 5.08